article Open AccessTop 1% cited
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
American Journal of Transplantation · 2020 · Vol. 20(9) · pp. 2318–2331
Alexandre Loupy✉(Inserm)Mark Haas✉(Cedars-Sinai Medical Center)Candice Roufosse(North West London Pathology)Maarten Naesens(KU Leuven)Benjamin Adam(University of Alberta)Marjan Afrouzian(The University of Texas Medical Branch at Galveston)Enver Akalin(Albert Einstein College of Medicine)Nada Alachkar(Johns Hopkins University)Serena M. Bagnasco(Johns Hopkins University)Jan U. Becker(University Hospital Cologne)Lynn D. Cornell(Mayo Clinic)Marian C. Clahsen‐van Groningen(Erasmus MC)Anthony J. Demetris(University of Pittsburgh)Duska Dragun(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)Jean–Paul Duong Van Huyen(Inserm)Alton B. Farris(Emory University)Agnes B. Fogo(Vanderbilt University)Ian W. Gibson(University of Manitoba)Denis Glotz(Inserm)Juliette Gueguen(Inserm)Željko Kikić(Medical University of Vienna)Nicolas Kozakowski(Medical University of Vienna)Edward S. Kraus(Johns Hopkins University)Carmen Lefaucheur(Inserm)Helen Liapis(Washington University in St. Louis)Roslyn B. Mannon(University of Alabama)Robert A. Montgomery(NYU Langone Health)Brian J. Nankivell(Westmead Hospital)Volker Nickeleit(University of North Carolina at Chapel Hill)Peter Nickerson(University of Manitoba)Marion Rabant(Inserm)Lorraine C. Racusen(Johns Hopkins University)Parmjeet Randhawa(University of Pittsburgh)Blaise Robin(Inserm)Ivy A. Rosales(Harvard University)Ruth Sapir‐Pichhadze(McGill University)Carrie A. Schinstock(Mayo Clinic)Daniel Serón(Universitat Autònoma de Barcelona)Harsharan K. Singh(University of North Carolina at Chapel Hill)R. Neal Smith(Harvard University)Mark D. Stegall(Mayo Clinic)Adriana Zeevi(University of Pittsburgh)Kim Solez(University of Alberta)Robert B. Colvin(Harvard University)Michael Mengel(University of Alberta)
Renal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and OutcomesTransplantation: Methods and OutcomesMedicineKidney transplantationTransplantationKidneyPathologyAntibodyDonor specific antibodiesOrgan transplantationHistocompatibilityIntensive care medicine
MeSH terms
Artificial IntelligenceGraft RejectionKidneyT-LymphocytesKidney Transplantation
Funding
- Novartis
- Elsevier Foundation
- HistoGenetics
- CSL Behring
Citations
774
FWCI
80.59
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
American Journal of Transplantation · 2020 · 774 citations
References
The Banff 97 working classification of renal allograft pathology
Kidney International · 1999 · 3,045 citations
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
American Journal of Transplantation · 2003 · 1,061 citations
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
American Journal of Transplantation · 2016 · 615 citations
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
American Journal of Transplantation · 2017 · 1,013 citations
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
Kidney International · 2018 · 951 citations
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
American Journal of Transplantation · 2020 · 774 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.